Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 07. August 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9027  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180535  
   
Mechanical stress, metabolic reprogramming and stromal remodeling: an emerging paradigm in the bladder cancer mechano-micro-environment.
Front Genet
Dong X, Chen Z, Chen Y, Xiao Z, Zhang J, Li Y, Du H.
PMID: 42559655 [PubMed]


Testing for Causal Association Between Serum Urate, Gout, and Prostatic Cancer in European Males.
Gout Urate Cryst Depos Dis
Chandrupatla S, Sumpter N, Takei R, Merriman TR, Singh J.
PMID: 42559566 [PubMed]


Structure-based redesign enables clinical translation of CAIX-targeted theranostics in clear cell renal cell carcinoma.
Theranostics
Xu Z, Zhou H, Dong Y, Feng D, Chen B, Li H, Yang R, Li N, Cao Y, He H, Wu H, Zhong Y, Wu H, Zhao L, Chen H, Hu K.
PMID: 42559379 [PubMed - indexed for MEDLINE]


PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.
Theranostics
Eder AC, Omrane MA, Matthias J, Stadlbauer S, Roscher M, Michalski K, Schick MA, Wielenberg CF, Bronsert P, Gratzke C, Freitag M, Kopka K, Eder M, Meyer PT, Jilg CA, Ruf J.
PMID: 42559208 [PubMed - indexed for MEDLINE]


Decoding the temporal dimension of innate immunity in intravesical BCG therapy.
Front Immunol
Diao X, Che B, Zhai J, Shao B, Tang K.
PMID: 42559128 [PubMed - indexed for MEDLINE]


Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study.
Ther Adv Urol
Skrobisz K, Miszewski K, Marczak B, Miszewska L, Kulski J, Matuszewski M.
PMID: 42558974 [PubMed]


From biology to morphology and treatment: the current role of pathology in penile cancer - a narrative review.
Front Oncol
Hrudka J, Zavillová N, Hojný J, Waldauf P, Mat.
PMID: 42558427 [PubMed]


Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm.
Front Oncol
Dai C, Zhang B, Deng Q, Feng J.
PMID: 42558352 [PubMed]


Tumor fat composition predicts response to everolimus and supports low-dose therapy in TSC-associated renal angiomyolipomas: a multicenter prospective study.
Front Oncol
Gao K, Duan Y, Ren B, Guo B, Su R, Gu H, Chen F, Zhang C, Wu G, Ni J.
PMID: 42558341 [PubMed]


Artificial intelligence in the early diagnosis of prostate cancer: from multimodal imaging to liquid biopsy.
Front Oncol
Xie J, Yin Z, Gao R, Qiu Z, Zhou Q.
PMID: 42558280 [PubMed]


Efficacy of Medical Interventions for Erectile Dysfunction after Prostate Cancer Treatment: A Systematic Review and Network Meta-Analysis.
World J Mens Health
Eshetie S, Ejekpokpo O, Charlick M, Tiruye T, Jay A, Higgs B, Shepherd A, Beckmann K.
PMID: 42557727 [PubMed - as supplied by publisher]


Bibliometric analysis of renal function preservation in robot-assisted partial nephrectomy: research trends, functional outcomes, and CKD-related perspectives.
J Robot Surg
Niu H, Xu C, Huang L, Tian Z, Man J, Yang L, Wang J.
PMID: 42557524 [PubMed - indexed for MEDLINE]


Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Nat Rev Urol
Hensley PJ, Teoh JYC, Li R, Gupta S, Bukavina L, Mouw KW, Lobo N, Maiorano BA, Tan WS, Agarwal P, Al-Ahmadie HA, Bivalacqua TJ, Cheng L, Flaig TW, Guo CC, Horowitz A, Kassouf W, Kates MR, Konety BR, Kukreja JB, Lotan Y, McConkey DJ, Mertens LS, Mir MC, Moschini M, Necchi A, Oualla K, Packiam VT, Schmidt B, Buckley RJ, Kamat AM.
PMID: 42557383 [PubMed - as supplied by publisher]


Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort.
Urol Oncol
Monaco A, Koh S, Guo A, Garcia RS, Ellis T, Palasi S, Lawen T, da Silva RD, Gregg JR.
PMID: 42557189 [PubMed - as supplied by publisher]


Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update.
Eur Urol Focus
Privé BM, Oprea-Lager DE, Muselaers CHJ, Timmermans B, van Oort IM, Mehra N, Michiel Sedelaar JP, Vrachimis A, Noordzij W, Nagarajah J.
PMID: 42557180 [PubMed - as supplied by publisher]


Bacillus Calmette-Guérin (BCG) with or without Immune Checkpoint Blockade in BCG-Naïve High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis.
Crit Rev Oncol Hematol
Saâd MA, Antari A, Taleb I, El Omri S, Traoré H, Chahbounia I, Sella I, Poudiougou A, Sano FD, Omri L, Elm'hadi C, Lamine S, Mokhlis MA, Aalaoui L, Debbagh A, Khmamouche MR, Slimani KA, Sbitti Y, Mahfoud T, Errihani H, Tanz R.
PMID: 42556596 [PubMed - as supplied by publisher]


Effectiveness and safety of hormonal doublet therapy in metastatic hormone-sensitive prostate cancer: A multicenter real-world study.
Actas Urol Esp (Engl Ed)
Guedes Oliva P, Pérez-Fentes D, De Pablos-Rodríguez P, Bardella-Altarriba C, Díaz-Pedrouzo A, Abuin-García J, Vera-Ballesteros FJ, Abella-Serra A, Ribera-Díaz D, Martínez-Corral ME, Gómez-Ferrer Á, Picola-Brau N, Martínez-Breijo S, Costa-Planells M, López-Abad A, García-Puche M, Jiménez Marrero P, Martínez Corral R.
PMID: 42551521 [PubMed - as supplied by publisher]


Prognostic clinical indicators in patients with metastatic castration-resistant prostate cancer treated with radium-223 plus enzalutamide: Data from patients in J-RAP-BSI trial.
Hell J Nucl Med
Kitajima K, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Yamamoto S, Narita M, Yamakado K.
PMID: 42555489 [PubMed - as supplied by publisher]


"Renal cell carcinoma, not otherwise specified" is not a sufficient diagnostic classification.
Virchows Arch
Yildirim NA, Bayrak BY, Cheng L, Akgul M.
PMID: 42554860 [PubMed - as supplied by publisher]


MRI Standards for Prostate Cancer Screening in the PRISM Consensus Recommendations.
AJR Am J Roentgenol
Ponsiglione A, Brembilla G.
PMID: 42554687 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 180535    Seite 1 von 9027  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1